Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, CSC, PASCAR, PCS, and PCSI. Challenges and special aspects of pulmonary hypertension in middle- to low-income regions: JACC state-of-the-art
(2022). Estimating Trends in Working Life Expectancy based on Health Insurance Data from Germany – Challenges and Advantages. SSM – Population Health. https://doi.org/10.1016/j.ssmph.2022.101215 Tübbecke F-M
1233) Harries L, Schrem H, Krauth C , Amelung VE (2021). Pathways in Transplantation Medicine: Challenges in Overcoming Interfaces Between Cross-sectoral Care Structures. In: Amelung VE, Stein V, Suter [...] : LIT Verlag. Harries L, Schrem H, Krauth C , Amelung V. Pathways in Transplantation Medicine: Challenges in Overcoming Interfaces Between Cross-Sectoral Care Structures. In: Amelung V, Stein V, Goodwin [...] Kreipe HH, Neil D, Kaltenborn A, Goldis A, Krauth C , Roberts K, Becker T Klempnauer J, Neuberger J. Challenges for the Development of Universal Prognostic Models in Liver Transplantation. Liver Transplantation
ation an 15. Jahrestagung des Deutschen Netzwerks Evidenzbasierte Medizin e.V. 13-15. März 2014, Halle, Deutschland. Abstract P14e. Gorenoi V , Schönermark MP, Hagen A. Die Kostenwirksamkeit der CT-Ko
1007/s00431-010-1149-z. Epub 2010 Feb 18. PMID: 20165869 Review. Gene therapy of MPL deficiency: challenging balance between leukemia and pancytopenia. Wicke DC, Meyer J, Buesche G, Heckl D, Kreipe H, Li
Mason C, Karlsson S. Mol Ther Methods Clin Dev 2020;20:312-323 DOI: 10.1016/j.omtm.2020.11.018 Challenges and advances in translating gene therapy for hearing disorders. Büning H, Schambach A, Morgan M [...] protects mice from mycobacterial infections. Hetzel M, Mucci A, Blank P, Nguyen AHH, Schiller J, Halle O, Kühnel MP, Billig S, Meineke R, Brand D, Herder V, Baumgärtner W, Bange FC, Goethe R, Jonigk D
Ahmad A, Koigeldiyev N, Pichlmaier M, Haverich A, Hagl C: Aortic root reoperation: a technical challenge. J Heart Valve Dis. 2010; 19, no. 2:177-81. 2009 Aper T, Haverich A, Teebken O: New developments
cellular reprogramming. Warlich E, Kuehle J, Cantz T, Brugman MH, Maetzig T, Galla M, Filipczyk AA, Halle S, Klump H, Schöler HR, Baum C, Schroeder T, Schambach A. Mol Ther. 2011 Apr;19(4):782-9. doi: 10
. Shum, I. O., Merkert, S., Malysheva, S., Jahn, K., Lachmann, N., Verboom, M., Frieling, H., Hallensleben, M., and Martin, U. 2023. An Improved Protocol for Targeted Differentiation of Primed Human Induced [...] org/10.1177/2047487319849505 . Engels, L., Olmer, R. , de la Roche, J., Göhring, G., Ulrich, S., Haller, R., Martin, U.# , and Merkert, S.#. 2019. Generation of a CFTR knock-in reporter cell line (MHHi006-A-1) [...] org/10.1016/j.addr.2017.09.004 . Martin, U. 2017. Therapeutic Application of Pluripotent Stem Cells: Challenges and Risks. Front Med (Lausanne) 4:229. https://doi.org/10.3389/fmed.2017.00229 . Martin, U. , and
zwischen Evidenz und Eminenz. 15. Jahrestagung des Deutschen Netzwerks Evidenzbasierte Medizin. Halle, 13.-15.03.2014. Düsseldorf: German Medical Science GMS Publishing House; 2014. Doc14ebmP8d. Dreier